{"id":"W1765269564","doi":"10.1111/j.1749-6632.2012.06804.x","title":"Phase II trial of methotrexate in myasthenia gravis","year":2012,"lang":"en","type":"article","venue":"Annals of the New York Academy of Sciences","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; U.S. Food and Drug Administration","keywords":"Prednisone; Methotrexate; Medicine; Myasthenia gravis; Internal medicine; Placebo; Corticosteroid; Randomized controlled trial; Cyclophosphamide; Gastroenterology; Pharmacology; Chemotherapy; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001316256,0.00104781,0.00155605,0.0002584491,0.0005226787,0.0006407028,0.0006816484,0.001465268,0.006255903],"category_scores_gemma":[0.001028769,0.000339289,0.0007341729,0.0003070977,0.0006947397,0.0003430628,0.0002278323,0.001968633,0.001033883],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001494682,"about_ca_system_score_gemma":0.002675627,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009369681,"about_ca_topic_score_gemma":0.02359271,"domain_scores_codex":[0.9995608,0.0002081583,0.00001616351,0.00006257441,0.00005431708,0.00009798291],"domain_scores_gemma":[0.9994111,0.00009613358,0.00008657491,0.00004325558,0.0000549441,0.0003079635],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9019838,0.02007956,0.003218917,0.000625878,0.000880814,0.000198295,0.0001294113,0.0006063569,0.009055519,0.0002786911,0.007210892,0.05573178],"study_design_scores_gemma":[0.8923674,0.09820736,0.005835543,0.00002842103,0.0001991381,0.00006630808,0.00002028152,0.0002237851,0.0004935344,0.00008773836,0.002462207,0.000008300894],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9655787,0.008141752,0.0005484604,0.00275938,0.0006366494,0.01066548,0.003029392,0.0002167153,0.008423464],"genre_scores_gemma":[0.9756078,0.003497707,0.001541635,0.002497748,0.0005090527,0.004934628,0.002970886,0.00001720169,0.008423535],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009369681,"threshold_uncertainty_score":0.02092803,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1584188904756389,"score_gpt":0.4168241368711996,"score_spread":0.2584052463955606,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}